Additionally, samples from other cancer types should also be analyzed to determine whether the presence of a specific humoral immune response to p53 and p63 proteoforms is specific to CRC, or would also be observed in other major solid tumors, and whether some proteoforms are also associated with different cancer types. The gene discussed is TP53; the disease is cancer.